Selexis SA and Berkeley Lights have formed a collaboration around the acquisition of Berkeley Lights’ Beacon optofluidic platform. The partners will leverage the technology to accelerate cell line development (CLD) with the Selexis SUREtechnology Platform. Selexis scientists have evaluated the Beacon technology and will now further incorporate it into the SUREtechnology Platform workflow. Utilizing the Beacon’s optofluidic and single cell analysis technology, the Selexis team says it has shorten...